COMPANY OVERVIEW

Embera is developing the first medication that treats addiction by moderating activity in the stress response system.

---

LOCATION

Sudbury, MA, USA

Shreveport, LA, USA

---

THERAPEUTIC AREAS

Neurological Disorders

---

WEBSITE

https://emberaneuro.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 30, 2021

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2a Study of EMB-001 in Smoking Cessation

Aug 31, 2020

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2 Study of EMB-001 in Cocaine Use Disorder

Dec 19, 2019

Embera NeuroTherapeutics Completes Series B Financing and Receives Grants to Advance EMB-001 into Phase 2 Clinical Studies in Cocaine Use Disorder and Smoking Cessation

Dec 12, 2017

Embera NeuroTherapeutics to Present at the 10th Annual Biotech Showcase

Oct 13, 2017

Embera NeuroTherapeutics to Present at the 2017 BIO Investor Forum

For More Press Releases

---